These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1295315)

  • 1. Introduction to in vivo targeting.
    Chiarantini L; Droleskey RE; DeLoach JR
    Adv Exp Med Biol; 1992; 326():269-77. PubMed ID: 1295315
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of erythrocytes to cytotoxic T-cells.
    Chiarantini L; Droleskey R; Magnani M; Kirch H; DeLoach JR
    Adv Exp Med Biol; 1992; 326():257-67. PubMed ID: 1295314
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL).
    Gasparini A; Chiarantini L; Kirch H; DeLoach JR
    Adv Exp Med Biol; 1992; 326():291-7. PubMed ID: 1295316
    [No Abstract]   [Full Text] [Related]  

  • 4. Report on monoclonal Rh antibodies serological and biochemical investigations.
    Bloy C; Blanchard D; Huet M; Hermand P; Celton JL; Cartron JP
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):209-21. PubMed ID: 3145550
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the epitopes recognized by monoclonal anti-D, anti-c and anti-E.
    Hughes-Jones NC; Gorick B; McDougall D; Melamed M; Thompson K
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):233-6. PubMed ID: 2463658
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-ordinator's report on group 3: monoclonal Rh antibodies: serological and biological studies.
    Tippett P
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):249-58. PubMed ID: 3145553
    [No Abstract]   [Full Text] [Related]  

  • 7. Report on group 8 (Lutheran) antibodies.
    Judson PA; Spring FA; Parsons SF; Anstee DJ; Mallinson G
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):433-40. PubMed ID: 3062738
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-related alteration in the effect of Thy-1 antibody on autorosette formation.
    Levy J; Schlesinger M; Rabinowitz R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):279-80. PubMed ID: 2908549
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro targeting of erythrocytes to cytotoxic T-cells by coupling of Thy-1.2 monoclonal antibody.
    Chiarantini L; Droleskey R; Magnani M; DeLoach JR
    Biotechnol Appl Biochem; 1992 Apr; 15(2):171-84. PubMed ID: 1586457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and biochemical characterization of monoclonal antibodies against red cell markers related to expression of Lutheran blood group antigens.
    Telen MJ; Green A; Young T
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):421-8. PubMed ID: 3212325
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigens on red cells.
    Anstee DJ
    Vox Sang; 1998; 74 Suppl 2():255-7. PubMed ID: 9704453
    [No Abstract]   [Full Text] [Related]  

  • 12. Variable requirement for murine lymphocyte function-associated antigen-1 (LFA-1) in T cell-mediated lysis depending upon the tissue origin of the target cells.
    Shimonkevitz R; Cerottini JC; MacDonald HR
    J Immunol; 1985 Sep; 135(3):1555-7. PubMed ID: 3160769
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effect of two monoclonal anti-Lyt-1 alloantibodies on lymphocyte distribution in vivo.
    Carroll AM; de Sousa M
    Immunology; 1984 Jun; 52(2):325-30. PubMed ID: 6234229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell rosetting is mediated by LFA-3 on autologous erythrocytes.
    Makgoba MW; Shaw S; Gugel EA; Sanders ME
    J Immunol; 1987 Jun; 138(11):3587-9. PubMed ID: 3108368
    [No Abstract]   [Full Text] [Related]  

  • 15. Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation.
    Bernard A; Tran HC; Boumsell L
    J Immunol; 1987 Jul; 139(1):18-23. PubMed ID: 2438349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins.
    Marches R; Mota G; Margineanu M; Stavri H; Savi G; Nicolae M; Bancu A; Moraru I
    Neoplasma; 1990; 37(5):573-8. PubMed ID: 2234217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular specificities of lymphocytotoxic alloantibodies from sensitized chronic renal failure patients.
    Sidgwick A; Horsburgh T; Bell PR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):773-4. PubMed ID: 3274870
    [No Abstract]   [Full Text] [Related]  

  • 18. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferative response of cloned CTL line 10B-5 upon stimulation with soluble clonotypic monoclonal antibody and its blocking by anti-Lyt-2 antibody.
    Udono H; Kuribayashi K; Fujita T; Mieno M; Shiku H; Nakayama E
    Immunobiology; 1989 Feb; 178(4-5):390-400. PubMed ID: 2785484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytolytic T lymphocytes by mitogenic lectins is specifically inhibited by anti-Lyt-2 antibodies.
    Gullberg M; Larsson EL
    Eur J Immunol; 1983 Jun; 13(6):476-80. PubMed ID: 6602709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.